DRI Healthcare to Host Second Quarter 2026 Earnings Call and Webcast on August 10, 2026
TORONTO, July 20, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its second quarter 2026 financial results on Monday, August 10, 2026, at 8:00 a.m. ET. DRI […]
DRI Healthcare Announces Exercise of Put Option on EKTERLY®
TORONTO, July 10, 2026 /CNW/ DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare“) today announced that it has exercised its contractual put option (the “Put Option“) with respect to DRI Healthcare’s royalty participation right in EKTERLY® (sebetralstat) for a total net repurchase price of approximately US$178 million (“Put Price“). The Put Option has been exercised in […]
DRI Healthcare Comments on Viridian’s FDA Approval and Launch of Lumvoa™ (veligrotug-vvze)
TORONTO, June 29, 2026 /CNW/ DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare“) today commented on Viridian Therapeutics, Inc.’s (“Viridian“) recently announced approval by the U.S. Food and Drug Administration (“FDA”) of Lumvoa™ (veligrotug-vvze) for the treatment of thyroid eye disease (“TED“). TED is an autoimmune inflammatory disorder of the orbit (eye socket) that affects numerous […]
DRI Healthcare Trust Announces Voting Results of Annual and Special Meeting
TORONTO, May 15, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”) is pleased to announce results of voting at its annual and special meeting of unitholders held on May 15, 2026. All of the nominees for election as trustees of DRI Healthcare referred to in its management information circular dated April 13, 2026 were elected […]
DRI Healthcare Reports First Quarter 2026 Results
TORONTO, March 14, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”) today announced its financial results for the quarter ended March 31, 2026. DRI Healthcare’s first quarter 2026 financial statements and Management’s Discussion & Analysis (“MD&A”) have been filed on SEDAR+ (www.sedarplus.ca). All dollar amounts are expressed in U.S. dollars unless otherwise indicated. “We began this […]
DRI Healthcare Trust Comments on Proposed Acquisition of KalVista Therapeutics, Inc.
TORONTO, April 29, 2026 /CNW/ DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare“) today noted the announcement by KalVista Therapeutics, Inc. (“KalVista”), that it has entered into a definitive agreement to be acquired by Chiesi Group, an international research-focused biopharmaceutical group (the “Transaction”). DRI Healthcare congratulates KalVista on the announced Transaction. As previously disclosed, DRI Healthcare […]
DRI Healthcare to Host First Quarter 2026 Earnings Call and Webcast on May 15, 2026
TORONTO, April 24, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its first quarter 2026 financial results on Friday, May 15, 2026, at 8:00 a.m. ET. DRI […]
DRI Healthcare Trust Announces Closing of US$250 Million of Senior Secured Notes
TORONTO, March 25, 2026 /CNW/ DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare“) is pleased to announce that its subsidiary, DRI Healthcare LP (the “Issuer“), has successfully closed its previously announced private placement offering consisting of two tranches of senior secured notes (together, the “Notes“): Interest on the Notes is payable semi-annually, and the Notes rank pari […]
DRI Healthcare Trust Announces Closing of Preferred Securities Refinancing
TORONTO, March 20, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare“) is pleased to announce that it has successfully completed the closing of the previously announced private placement offering of convertible unsecured subordinated debentures (the “Debentures“) in the aggregate principal amount of C$108,723,000. The principal sum of the Debentures bear interest at the rate of 5.75% […]
DRI Healthcare Reports Fourth Quarter and Annual 2025 Results
TORONTO, March 3, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”) today announced its financial results for the quarter ended and year ended December 31, 2025. DRI Healthcare’s annual 2025 financial statements and Management’s Discussion & Analysis (“MD&A”) have been filed on SEDAR+ (www.sedarplus.ca). All dollar amounts are expressed in U.S. dollars unless otherwise indicated. “2025 marked […]